Alpine Immune Sciences (NASDAQ: ALPN)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price

N/A

Daily Change

N/A

Day's Range

N/A

Previous Close

N/A

Open

N/A

Beta

N/A

Volume

N/A

Average Volume

N/A

Sector

Health Care

Market Cap

N/A

Market Cap / Employee

N/A

52wk Range

N/A

Revenue

N/A

Gross Margin

N/A

Dividend Yield

N/A

EPS

N/A

CAPs Rating

N/A

Industry

Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Alpine Immune Sciences Company Info

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.